The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at

Bayer RSS Channel

Title Filter      Display #  
# Article Title
1 Bayer forms collaboration with academic and governmental institutions for Rivaroxaban study
2 Bayer operationally strong - strategic focus on Life Science businesses
3 Bayer supports World Thrombosis Day as founding global partner
4 Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion
5 Safety and sustained benefits of Adempas® from Bayer confirmed by results of long-term studies
6 Bayer continues positive business development
7 Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment
8 Bayer HealthCare extends access to clinical trial data
9 Bayer: Very successful start to 2014
10 Bayer HealthCare to significantly increase production capacity in China
11 Bayer to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development
12 Bayer and Peking University establish new research center for translational research and drug discovery in Beijing
13 Bayer plans to acquire Norwegian pharmaceutical company Algeta
14 Bayer CEO Marijn Dekkers calls for greater appreciation of innovation
15 Bayer continues positive business momentum
16 Bayer accelerates clinical development of promising new drug candidates
17 Olivier Brandicourt appointed as new CEO of Bayer HealthCare
18 Bayer's investigational drug Riociguat granted FDA orphan drug designation
19 Bayer fights Chagas disease in Argentina together with Caritas
20 Nexavar® (sorafenib) granted priority review for differentiated thyroid cancer in the U.S.
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]